Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$111M |
| 2 |
Verizon
VZ
|
+$103M |
| 3 |
AT&T
T
|
+$103M |
| 4 |
Kroger
KR
|
+$97.1M |
| 5 |
3M
MMM
|
+$92.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$138M |
| 2 |
Tesla
TSLA
|
+$110M |
| 3 |
JPMorgan Chase
JPM
|
+$103M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$89.4M |
| 5 |
Apple
AAPL
|
+$85.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 16.26% |
| 3 | Financials | 11.97% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
TD Synnex
SNX
$19.7B
| $14.9M | 0.03% |
157,893
+54,052
| +52% | +$5.06M |
|
552
KeyCorp
KEY
$23.2B
| $14.9M | 0.03% |
853,704
-889,892
| -51% | -$15.7M |
|
553
EPR Properties
EPR
$4.65B
| $14.8M | 0.03% |
396,574
+125,713
| +46% | +$4.89M |
|
554
Qualys
QLYS
$6.1B
| $14.8M | 0.03% |
132,463
+43,585
| +49% | +$5.44M |
|
555
GoDaddy
GDDY
$12.6B
| $14.8M | 0.03% |
198,458
-68,922
| -26% | -$5.17M |
|
556
Vornado Realty Trust
VNO
$7.18B
| $14.8M | 0.03% |
709,845
+328,253
| +86% | +$7.52M |
|
557
Assured Guaranty
AGO
$3.29B
| $14.6M | 0.03% |
236,240
-8,874
| -4% | -$526K |
|
558
Boise Cascade
BCC
$2.86B
| $14.6M | 0.03% |
211,894
+30,472
| +17% | +$2.08M |
|
559
Copart
CPRT
$30.7B
| $14.4M | 0.03% |
474,498
-237,970
| -33% | -$7.12M |
|
560
Starbucks
SBUX
$123B
| $14.3M | 0.03% |
145,031
-133,187
| -48% | -$12.6M |
|
561
Markel Group
MKL
$22.5B
| $14.3M | 0.03% |
10,887
-4,322
| -28% | -$5.35M |
|
562
Allegion
ALLE
$13.8B
| $14.3M | 0.03% |
135,665
-97,143
| -42% | -$10.1M |
|
|
DISH
563
DELISTED
DISH Network Corp.
DISH
| $14.2M | 0.03% |
1,016,770
+140,754
| +16% | +$2.08M |
|
564
Bio-Rad Laboratories Class A
BIO
$10.1B
| $14.2M | 0.03% |
33,993
-5,800
| -15% | -$2.34M |
|
|
VMW
565
DELISTED
VMware, Inc
VMW
| $14.2M | 0.03% |
116,393
-8,527
| -7% | -$983K |
|
566
Arch Capital
ACGL
$34.5B
| $14M | 0.03% |
223,573
-395,456
| -64% | -$22.1M |
|
|
PCH
567
DELISTED
PotlatchDeltic
PCH
| $13.9M | 0.03% |
316,617
-56,745
| -15% | -$2.57M |
|
|
EFOR
568
Everforth Inc
EFOR
$1.32B
| $13.9M | 0.03% |
170,406
+38,828
| +30% | +$3.41M |
|
569
Cheniere Energy
LNG
$57.7B
| $13.9M | 0.03% |
93,597
-32,369
| -26% | -$5.42M |
|
570
Bio-Techne
TECH
$11.3B
| $13.6M | 0.03% |
164,781
+18,957
| +13% | +$1.51M |
|
571
Hubbell
HUBB
$24.7B
| $13.6M | 0.03% |
58,183
-5,769
| -9% | -$1.38M |
|
572
Revvity
RVTY
$13.7B
| $13.4M | 0.03% |
95,852
-57,270
| -37% | -$7.71M |
|
|
SWN
573
DELISTED
Southwestern Energy Company
SWN
| $13.4M | 0.03% |
2,293,195
+2,063,321
| +898% | +$13.6M |
|
574
Radian Group
RDN
$4.85B
| $13.4M | 0.03% |
703,321
+227,250
| +48% | +$4.42M |
|
575
WillScot Mobile Mini Holdings
WSC
$4.02B
| $13.4M | 0.03% |
298,570
-35,005
| -10% | -$1.57M |
|
Similar funds
Cliff Asness's Q4 2022 Portfolio in Review
As of Q4 2022, Cliff Asness held 2,343 positions worth $43.9B, up 7% from $41B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Cliff Asness's Q4 2022 filing shows 170 new, 997 increased, 1,015 reduced and 150 closed positions. Its largest new stake was Generac Holdings: 310,080 shares worth $30.5M. The largest sale was Gilead Sciences, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Cliff Asness's largest Q4 2022 buy was Generac Holdings: 310,080 shares worth $30.5M.
- Cliff Asness added most to Humana in Q4 2022, an estimated $111M increase.
- Cliff Asness's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $138M.
- Cliff Asness fully exited Abiomed Inc in Q4 2022, selling an estimated $22.4M.
- Cliff Asness's ten largest holdings make up 13% of its $43.9B portfolio in Q4 2022.
- Cliff Asness opened 170 new positions and closed 150 in Q4 2022.
- Cliff Asness's portfolio value rose 7% quarter-over-quarter to $43.9B.
Based on AQR Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.